title: Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.
abstract: OBJECTIVE
  To examine recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids for the treatment of asthma among Saskatchewan residents and to determine whether these trends are in keeping with widely publicized guidelines recommending a reduction in the use of agents to treat symptoms (i.e., inhaled beta 2-adrenergic agonists) and increased use of prophylactic agents (i.e., inhaled corticosteroids).
  
  
  METHODS
  Descriptive pharmacoepidemiologic study conducted with the use of data from the computerized database of the Saskatchewan Prescription Drug Plan.
  
  
  METHODS
  Saskatchewan.
  
  
  METHODS
  Saskatchewan residents 5 to 54 years of age who received one or more outpatient prescriptions for drugs to treat asthma (inhaled drugs, ingested beta 2-adrenergic agonists and ingested methylxanthines) from 1989 to 1993.
  
  
  METHODS
  Epidemiologic trends, calculated for each year: number of prescriptions per 1,000 persons; number of patients who received prescriptions for inhaled corticosteroids, inhaled beta 2-adrenergic agonists and any type of drug to treat asthma; mean number of such prescriptions per patient; and weighted mean amount of salbutamol, fenoterol and beclomethasone dispensed per patient.
  
  
  RESULTS
  There has been an increase in the proportion of the population receiving prescriptions for drugs to treat asthma. The number of patients receiving these drugs per 1,000 people rose during the study period from 33.38 to 46.59 for any drug to treat asthma, from 24.70 to 33.77 for inhaled beta 2-adrenergic agonists and from 6.1 to 19.9 for inhaled corticosteroids. The mean number of prescriptions per patient decreased steadily for all drugs to treat asthma (from 5.34 in 1989 to 3.88 in 1993), for inhaled beta 2-adrenergic agonists (from 4.35 to 3.09) and for inhaled corticosteroids (from 2.98 to 2.25). The weighted mean amount of inhaled salbutamol dispensed per patient per year decreased by 40%, from 178.08 mg in 1989 to 109.14 mg in 1993. The weighted amount of fenoterol dispensed per patient per year declined even more, by 58%, from 387.91 mg in 1989 to 164.00 mg in 1993. Conversely, the weighted amount of inhaled beclomethasone dispensed per patient per year increased by 35% from 46.95 mg in 1989 to 63.50 mg in 1992, then dropped to 56.17 mg per year in 1993.
  
  
  CONCLUSIONS
  These data demonstrate a substantial change in Saskatchewan in the prescribing of drugs to treat asthma; they suggest that many physicians responded to current guidelines advocating increased attention to prevention of airway inflammation in the treatment of asthma.
authors.affiliation: Department of Community Health and Epidemiology, Royal University Hospital, Saskatoon SK.
authors.forename: B
authors.initials: B
authors.lastname: Habbick
authors.forename: M J
authors.initials: MJ
authors.lastname: Baker
authors.forename: M
authors.initials: M
authors.lastname: McNutt
authors.forename: D W
authors.initials: DW
authors.lastname: Cockcroft
mesh_terms: D000280:Administration, Inhalation; D000287:Administration, Topical; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D000336:Aerosols; D000420:Albuterol / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D019819:Budesonide; D002648:Child; D002675:Child, Preschool; D011307:Drug Prescriptions; D017723:Drug Utilization Review; D005280:Fenoterol / Q000008:administration & dosage; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives; D005938:Glucocorticoids; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage; D009921:Metaproterenol / Q000008:administration & dosage; D008875:Middle Aged; D011282:Pregnenediones / Q000008:administration & dosage; D017265:Procaterol / Q000008:administration & dosage; D012525:Saskatchewan; D014221:Triamcinolone / Q000008:administration & dosage
chemical_list: D000318:Adrenergic beta-Agonists; D000336:Aerosols; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D011282:Pregnenediones; D005446:Fluocinolone Acetonide; D014221:Triamcinolone; D005280:Fenoterol; D019819:Budesonide; D009921:Metaproterenol; C007734:flunisolide; D001507:Beclomethasone; D007545:Isoproterenol; D000420:Albuterol; D017265:Procaterol